Haleon PLC (GB:HLN) has released an update.
Haleon PLC has released its Q3 trading update for 2024, showcasing its performance across its robust portfolio of consumer health products, including well-known brands like Advil and Sensodyne. The company continues to leverage its expertise in oral health, pain relief, and other key categories to drive growth. Analysts and shareholders were invited to a presentation led by CFO Tobias Hestler to discuss the results in detail.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
